SCHEMBL6697349

SCHEMBL6697349

NCCC(=O)CCC(=O)CCC(=O)CCN

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 2/20 0.45
LMNA P02545 3/20 0.40
THRB P10828 2/20 0.40
BLM P54132 2/20 0.40
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TSHR P16473 2/20 0.40
CYP1A2 P05177 2/20 0.40
GABRR3 A8MPY1 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
HDAC3 O15379 1/20 0.40
GABBR2 O75899 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRR2 P28476 1/20 0.40
SLC6A1 P30531 1/20 0.40
GABRA5 P31644 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4705539 1.00 GABRR1 (0.45) GABRR1LMNATHRBBLMKMT2A
SCHEMBL1640046 0.96
Hydrochloric Acid SCHEMBL2708490 0.92 BLM (0.43) GABRR1LMNATHRBBLMKMT2A
SCHEMBL5067741 0.87 TSHR (0.39) GABRR1LMNATHRBBLMKMT2A
SCHEMBL30593457 0.87 GABRR1 (0.65) GABRR1LMNATHRBBLMKMT2A
SCHEMBL251587 0.87 TSHR (0.39) GABRR1LMNATHRBBLMKMT2A
SCHEMBL16585471 0.87 GABRR1 (0.65) GABRR1LMNATHRBBLMKMT2A
SCHEMBL28517809 0.87 GABRR1 (0.65) GABRR1LMNATHRBBLMKMT2A
SCHEMBL23438057 0.85 TDP1 (0.47) GABRR1LMNATHRBBLMKMT2A
SCHEMBL5860126 0.85 ALDH1A1 (0.56) GABRR1LMNATHRBBLMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040253184-A1 Targeted polymerized liposome diagnostic and treatment agents TARGESOME, INC. 2004-12-16 US disclosed
US-6569451-B1 Hydrophilic head group of lipid and liposome-forming lipid and a bifunctional linker; polymerizable tail; metal diethylene-triamine pentaacetic acid chelate is head and bifunctional linker is polyethylene glycol, propylene glycol or polyglycine TARGESOME, INC. 2003-05-27 US disclosed
US-20020071843-A1 Targeted therapeutic agents TARGESOME, INC. 2002-06-13 US disclosed
US-6350466-B1 COMPOSITION COMPRISING PARTICLES EACH COMPRISING SHEET CONTAINING LIPIDS WITH HYDROPHOBIC TAIL GROUP COVALENTLY CROSSLINKED WITH THAT OF ADJACENT LIPID, EACH PARTICLE FURTHER COMPRISING TARGETING AGENT AND SUBSTANCE FOR DELIVERY TARGESOME, INC. 2002-02-26 US disclosed
US-6132764-A MAGNETIC RESONANCE IMAGING SIGNAL ENHANCEMENT OF TARGETED CELLS, LIVER AND KIDNEY; IN VIVO STABILITY; DIAGNOSING ABNORMAL PATHOLOGY; TARGETING DELIVERY POLYMERIZED LIPOSOME PARTICLES TARGETED TO MOLECULE AT OR NEAR SITE OF TREATMENT TARGESOME, INC. (US) 2000-10-17 US disclosed
US-6090408-A Use of polymerized lipid diagnostic agents TARGESOME, INC. (US) 2000-07-18 US disclosed
US-5512294-A MEDICAL DIAGNOSIS, IMAGING NANOVALENT PHARMACEUTICALS, INC. 1996-04-30 US disclosed